Literature DB >> 1662690

Baculovirus expression of the human papillomavirus type 16 capsid proteins: detection of L1-L2 protein complexes.

S Z Xi1, L M Banks.   

Abstract

The human papillomavirus (HPV) type 16 major capsid proteins L1 and L2 have been produced in a baculovirus expression system. Both proteins are expressed at a high level and can be readily solubilized. The L1 capsid protein migrates close to its expected Mr of 60K. On the other hand L2 exhibits a much higher Mr migrating at 73K, which is considerably greater than its predicted Mr of 50K. The identity of both proteins has been confirmed also by Western blot analysis. Both proteins are produced in drastically reduced amounts in the presence of tunicamycin. In addition both L1 and L2 show interesting patterns of phosphorylation. L1 is phosphorylated only weakly and this appears to be quite labile, whereas L2 is very heavily phosphorylated and this, in contrast, appears to be very stable. We have also made use of a dual expression vector for co-expressing the L1 and L2 proteins within the same baculovirus-infected cell. The results obtained from this system demonstrate the presence of protein complexes forming between the two capsid proteins. These studies indicate that at least the initial events in capsid assembly of HPVs can occur in the absence of viral DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662690     DOI: 10.1099/0022-1317-72-12-2981

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

2.  Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies.

Authors:  Joshua W Wang; Subhashini Jagu; Kihyuck Kwak; Chenguang Wang; Shiwen Peng; Reinhard Kirnbauer; Richard B S Roden
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

3.  Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs.

Authors:  P Vidyasagar; V N Sridevi; S Rajan; A Praveen; A Srikanth; G Abhinay; V Siva Kumar; R R Verma; L Rajendra
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

4.  Phosphorylation status of the parvovirus minute virus of mice particle: mapping and biological relevance of the major phosphorylation sites.

Authors:  B Maroto; J C Ramírez; J M Almendral
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.

Authors:  Justyna Broniarczyk; Paola Massimi; David Pim; Martina Bergant Marušič; Michael P Myers; Robert L Garcea; Lawrence Banks
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

6.  Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.

Authors:  M P McCarthy; W I White; F Palmer-Hill; S Koenig; J A Suzich
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Authors:  R Kirnbauer; J Taub; H Greenstone; R Roden; M Dürst; L Gissmann; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

Authors:  R C Rose; W Bonnez; R C Reichman; R L Garcea
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.

Authors:  J Zhou; X Y Sun; K Louis; I H Frazer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.

Authors:  T Yamada; C M Wheeler; A L Halpern; A C Stewart; A Hildesheim; S A Jenison
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.